期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

维持性血液透析患者血清镁、甲状旁腺激素和血脂代谢的相关研究 被引量：7

暂未订购
导出
摘要 目的探讨维持性血液透析患者的血脂代谢与血清镁、甲状旁腺激素之间的关系。方法对60例行血液透析的患者(血液透析组)检测总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、血清镁(Mg)、甲状旁腺激素(PTH),随机选取60例无肾脏病的健康体检对象为对照组。结果血液透析组的PTH、TG及LDL-C较对照组明显升高(P<0.05),HDL-C明显下降(P<0.05),Mg和TC在2组间差异无统计学意义(P>0.05)。血清镁与HDL-C呈正相关(P<0.05);血清镁与LDL-C呈负相关(P<0.05);血清镁与TG、TC无相关性(P>0.05)。PTH与TG、LDL-C呈正相关(P<0.05);PTH与TC、HDL-C无相关性(P>0.05)。结论脂代谢异常是终末期肾病维持性血液透析患者常见的并发症,血清镁、PTH可能与血脂代谢有一定的相关性。
作者 张驰
机构地区 首都医科大学宣武医院检验科
出处 《河北医药》 CAS 2013年第2期205-206,共2页 Hebei Medical Journal
关键词 血液透析 镁 甲状旁腺激素 血脂
分类号 R459.52 [医药卫生—治疗学]
  • 相关文献

参考文献12

  • 1Wakeel JS, Mitwalli AH, Mohaya S, et al. Morbidity and mortality in ESRD patients on dialysis. Saudi J Kidney Dis Transpl, 2002,13:473- 477.
  • 2Muhammad RA, Narinder M. Correlation of serum magnesium with dyslip- idemia in patients on maintenance hemodialysis. Saudi J Kidney Dis Transpl, 2012,23 : 21-25.
  • 3Evenepoel P, Claes K, Kuypers D, et al. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients a s ingle centre study. Nephrul Dial Transplant, 2005,20: 1714-1720.
  • 4Avram MM, Goldwasser P, Burrell DE, et al. The uremic dyslipidemia: a cross-sectional and longitudinal study. Am J Kidney Dis, 1992,20:324- 335.
  • 5Navarro JF, Teruel JL, Lasuncitn MA, et al. Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. E- volution of lipid parameters after parathyroidectomy. Clin Nephrol, 1998, 49 : 303-307.
  • 6Navarro JF, Mora C, Macia M, et al. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis natients. Petit Dial lnt. 1999_ 19.455-461.
  • 7赵战芝,杨永宗.低镁血症在动脉粥样硬化发病中的作用[J].心血管病学进展,2004,25(6):450-453. 被引量：9
  • 8Song Y,He K,Levitan EB,et al. Effects of oral magnesium supplementa- tion on glycaemic control in Type 2 diabetes : a meta-analysis of random- ized double-blind on trolled trials. Diabet Med ,2006,23:1050-1056.
  • 9Huang MS, Lu J, Ivanov Y, et al. Hyperlipidemia impairs osteoanabolic effects of PTH..1 Bone Miner Res,2008,23:1672-1679.
  • 10陈军,黄国明.镁与动脉粥样硬化[J].国际内科学杂志,2007,34(7):394-396. 被引量：4

二级参考文献30

  • 1季大玺.高通量血液透析的可能益处[J].中国血液净化,2005,4(7):349-351. 被引量：76
  • 2季大玺.高通量血液透析的新认识[J].中国中西医结合肾病杂志,2005,6(10):559-562. 被引量：13
  • 3Nasri H.Serum leptin concentration and left ventricular hypertrophy and function in maintenance hemodialysis patients.Minerva Urol Nefrol,2006,58:189-193.
  • 4Van Telingen A,Grooteman MP,Schoorl M,et al.Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.Nephrol Dial Transplant,2004,19:1198-1203.
  • 5Mallamaci F,Tripepi G,Zoccali C.Leptin in end stage renal disease(ESRD):a link between fat mass,bone and the cardiovascular system.J Nephrol,2005,18:464-468.
  • 6Kuwahara M,Inoshita S,Nakano Y,et al.Expression of bone type PTH receptor in rats with chronic renal failure[J].Clin Exp Nephrol,2007,11(1):34-40.
  • 7Sander C,Frand MS,Rostand SC.Metastatic calification of the heart and lungs in end-stage renal disease:Detection and quantification by dual energy digital chest radiography[J].Am J Roent,1987,149:881-890.
  • 8Kisters K,Tokmak F,Gremmler B,et al,Increased calcium/magnesium ratio in young and old spontaneously hypertensive rats:Pathogenetic factor in the development of hypertension and vascular fibrasis.Am J Hypertens,2005,18(2):295-299.
  • 9Kisters K,Wessels F,Kuper H,et al.Increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in spontaneously hypertensive rats versus Wistar.Kvoto rats:relation to arteriosclerosis.Am J Hypertens,2004,17(1):59-62.
  • 10Pitero D.Magnesium and coronary heart disese.Mol Aspects Med,2003,24:63-78.

共引文献19

同被引文献77

  • 1顾勇.应充分重视和保护透析患者残余肾功能[J].中华肾脏病杂志,2007,23(7):411-412. 被引量：42
  • 2Navarro J, Mora C, Garcia J. Clinical implications of disordered magnesium homeostasis in chronic renal fail- ure and dialysis[I]. Semin Dial, 2009, 22(1):37-44.
  • 3GUnther T. Mechanisms and regulation of Mg2 + efflux and Mg2 + influx[J]. Miner Electrolyte Metab, 1993, 19 (4-5):259-265.
  • 4Elin RJ. Magnesium metabolism in health and disease [J]. Dis Mon, 1988, 34(4):161-218.
  • 5Saha H, Harmoinen A, Pietila K, et al. Measurement of serum ionized versus total levels of magnesium and cal- cium in hemodialysis patients[J]. Clin Nephrol, 1996, 46(5):326 -331.
  • 6Navarro 3, Mora C, Maeia M, et al. Serum magnesium con-centration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients[J]. Perit Dial Int, 1999, 19(5):455-461.
  • 7Guillot AP, Hood VL, Runge CF, er al. The use of magne- sium-containing phosphate binders in patients with end- stage renal disease on maintenance haemodialysis[J]. Nephron, 1982, 30(2):114-117.
  • 8Gonella M, Ballanti P, Della-Roca C, et al. Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients[J]. Miner Electro- lyte Metab, 1988, 14(4):240-245.
  • 9Louvet L, Bazin D, BUehel J, et al. ~haracterisation of calcium phosphate crystals on calcified human aor- tic vascular smooth muscle cells and potential role of magnesium[J]. PLoS One, 2015, 10:e0115342.
  • 10Tzanakis I, Pras A, Kounali D, et al. Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium[J]. Nephrol Dial Trans- plant, 1997, 12: 2036-2037.

引证文献7

二级引证文献50

河北医药
2013年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部